AMGEN REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St futures steady with focus on Mideast talks, US-China summit
- Oil holds near two-week lows while diesel cracks hit record peak
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
Amgen (AMGN) Tops Q2 EPS by 26c, Offers Guidance
August 4, 2022 4:03 PM EDTAmgen (NASDAQ: AMGN) reported Q2 EPS of $4.65, $0.26 better than the analyst estimate of $4.39. Revenue for the quarter came in at $6.59 billion versus the consensus estimate of $6.53 billion.
GUIDANCE:
Amgen sees FY2022 EPS of $17.00-$18.00, versus the consensus of $17.40. Amgen sees... More
